Thank you for your kind words. Here's that interview with CEO Darryl Davies I mentioned on another thread.
It's pretty dry but a solid and up-to-date summary of where the company's at.
If it's too long, scroll forward to the 24 minute and 25 second mark. This is where the Q & A starts.
He gets asked a fair few pertinent questions re funding, competition, patents, M & A talks, and the key difference between synthetic opioids vs synthetic THC.
InhaleRx (ASX:IRX) | Webinar with Darryl Davies | 25/07/24 - YouTube
GLTAH
THE BUY CASE, page-24
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.882M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 80 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 58388 | 1 |
View Market Depth
| Last trade - 16.12pm 30/08/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable